TVM Life Science Ventures VI GmbH & Co KG's Net Worth
$2.43 Million
Who is TVM Life Science Ventures VI GmbH & Co KG?
TVM Life Science Ventures VI GmbH & Co KG has an estimated net worth of $2.43 Million. This is based on reported shares across multiple companies, which include CONCERT PHARMACEUTICALS, INC., PROTEON THERAPEUTICS INC, and Acer Therapeutics Inc..
SEC CIK
TVM Life Science Ventures VI GmbH & Co KG's CIK is 0001599744
Past Insider Trading and Trends
2014 was TVM Life Science Ventures VI GmbH & Co KG's most active year for acquiring shares with 14 total transactions. TVM Life Science Ventures VI GmbH & Co KG's most active month to acquire stocks was the month of January. 2014 was TVM Life Science Ventures VI GmbH & Co KG's most active year for disposing of shares, totalling 20 transactions. TVM Life Science Ventures VI GmbH & Co KG's most active month to dispose stocks was the month of September. 2017 saw TVM Life Science Ventures VI GmbH & Co KG paying a total of $4,871,996.00 for 2,398,181 shares, this is the most they've acquired in one year. In 2014 TVM Life Science Ventures VI GmbH & Co KG cashed out on 29,721,956 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONCERT PHARMACEUTICALS, INC. No price found
InvestorTVM Life Science Ventures VI GmbH & Co KG owns 1,483,672 units of Common Stock. In the year 2014 TVM Life Science Ventures VI GmbH & Co KG filed a total of 2 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +2,694.27% | 1.43M |
$14.00 |
—
| 1.48M |
Feb 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
PROTEON THERAPEUTICS INC (TARA) Snapshot price: $2.72
InvestorTVM Life Science Ventures VI GmbH & Co KG owns 3,846,186 units of Common Stock which is worth $10,461,625.92. From 2014 to 2017 TVM Life Science Ventures VI GmbH & Co KG acquired a total of 1,943,059 shares in PROTEON THERAPEUTICS INC at a cost of $3,719,997.62.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +34.57% | 1.94M |
$7.30 | $3,719,997.62 | 7.56M |
Oct 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Acer Therapeutics Inc. (ACER) Snapshot price: $0.6601
InvestorTVM Life Science Ventures VI GmbH & Co KG owns 1,422,709 units of Common Stock which is worth $939,130.21. In the year 2017 TVM Life Science Ventures VI GmbH & Co KG acquired a total of 2,397,309 shares in Acer Therapeutics Inc. at a cost of $3,999,996.00.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +16.15% | 333.33K |
$12.00 | $3,999,996.00 | 2.4M |
Dec 12
| |||
Form 4
|
∞
| 2.06M |
—
|
—
| 2.06M |
Sep 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |